Zvi Yaari

Zvi Yaari

Auto-generated profile, based on publicly available information

Zvi Yaari

Hebrew University of Jerusalem

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YBYoav Binenbaum
Yoav Binenbaum
EFEran Fridman
Eran Fridman
ZYZvi Yaari
Zvi Yaari
NMNeta Milman
Neta Milman
ASAvi Schroeder
Avi Schroeder
Ziv GilZiv Gil
Ziv Gil
Pancreatic ductal adenocarcinoma (PDAC) is known for its resistance to gemcitabine, which acts to inhibit cell growth by termination of DNA replication. Tumor-associated macrophages (TAM) were recently shown to contribute to gemcitabine resistance; however, the exact mechanism of this process is still unclear. Using a genetic mouse model of PDAC and electron microscopy analysis, we show that TAM communicate with the tumor microenvironment via secretion of approximately 90 nm vesicles, which are selectively internalized by cancer cells. Transfection of artificial dsDNA (barcode fragment) to murine peritoneal macrophages and injection to mice bearing PDAC tumors revealed a 4-log higher concentration of the barcode fragment in primary tumors and in liver metastasis than in normal tissue. These macrophage-derived exosomes (MDE) significantly decreased the sensitivity of PDAC cells to gemcitabine, in vitro and in vivo. This effect was mediated by the transfer of miR-365 in MDE. miR-365 impaired activation of gemcitabine by upregulation of the triphospho-nucleotide pool in cancer cells and the induction of the enzyme cytidine deaminase; the latter inactivates gemcitabine. Adoptive transfer of miR-365 in TAM induced gemcitabine resistance in PDAC-bearing mice, whereas immune transfer of the miR-365 antagonist recovered the sensitivity to gemcitabine. Mice deficient of Rab27 a/b genes, which lack exosomal secretion, responded significantly better to gemcitabine than did wildtype. These results identify MDE as key regulators of gemcitabine resistance in PDAC and demonstrate that blocking miR-365 can potentiate gemcitabine response. Significance: Harnessing macrophage-derived exosomes as conveyers of antagomiRs augments the effect of chemotherapy against cancer, opening new therapeutic options against malignancies where resistance to nucleotide analogs remains an obstacle to overcome. Cancer Res; 78(18); 5287–99. ©2018 AACR.

10 November 2016 in Nature Communications
Verified
Journal Article
Open access
ZYZvi Yaari
Zvi Yaari
DSDana da Silva
Dana da Silva
AZAssaf Zinger
Assaf Zinger
EGEvgeniya Goldman
Evgeniya Goldman
AKAshima Kajal
Ashima Kajal
ASAvi Schroeder
Avi Schroeder
Personalized medicine promises to revolutionize cancer therapy by matching the most effective treatment to the individual patient. Using a nanoparticle-based system, we predict the therapeutic potency of anticancer medicines in a personalized manner. We carry out the diagnostic stage through a multidrug screen performed inside the tumour, extracting drug activity information with single cell sensitivity. By using 100 nm liposomes, loaded with various cancer drugs and corresponding synthetic DNA barcodes, we find a correlation between the cell viability and the drug it was exposed to, according to the matching barcodes. Based on this screen, we devise a treatment protocol for mice bearing triple-negative breast-cancer tumours, and its results confirm the diagnostic prediction. We show that the use of nanotechnology in cancer care is effective for generating personalized treatment protocols.

19 November 2021 in Science Advances
Verified
Journal Article
Open access
ZYZvi Yaari
Zvi Yaari
YYYoona Yang
Yoona Yang
EAElana Apfelbaum
Elana Apfelbaum
CCChristian Cupo
Christian Cupo
ASAlex H. Settle
Alex H. Settle
DHDaniel A. Heller
Daniel A. Heller
Machine learning–enabled perception-based detection of protein biomarkers was achieved in gynecologic cancer patient biofluids.

9 August 2024 in ECS Meeting Abstracts
Verified
Journal Article
Closed access
ZYZvi Yaari
Zvi Yaari
Novel biomedical application technologies have been rapidly improved in the past few decades. Despite recent technological progress, significant challenges persist toward more accessible, precise, inexpensive, rapid, automated, and patient-facing methods. Optical spectroscopic and imaging technologies have multiple advantages to current practices, such as versatility, fast and robust signal, and noninvasive and nondestructive probing techniques that can be easily integrated into current medical devices such as catheters, endoscopes, or biopsy needle channels. Single-walled carbon nanotubes (SWCNTs) have been developed as near-infrared (NIR) fluorescent nanosensors and demonstrated in vitro and in vivo with great interest for using them in biological and clinical applications and the methods designed to probe them. The advantages of SWCNT include resistance to photobleaching and high sensitivity towards biological environments. Gynecologic cancers are challenging to diagnose. Patient prognosis and quality of life are affected substantially by this problem. In this talk, I will present recent work on developing new technologies to improve gynecological cancer detection and grant new research tools for understanding fundamental mechanisms in cancer development using liquid biopsy and in vitro and in vivo sensor approaches. With artificial intelligence algorithms, we harness SWCNTs' unique optical properties and sensitivity to develop intelligent optical sensors. We developed platforms to detect multiple gynecological cancer biomarkers as implantable devices in patient biofluids and the uterine cavity. Applying machine learning algorithms to analyze the optical response of the sensors enabled the precise detection of multiplexed biomarkers. In addition, when implanted in human uteri, the sensors detected the biomarkers and successfully differentiated between benign and malignant cases. These technologies will significantly improve diagnostics and cancer research, leading to robust, point-of-care technologies for early-stage diagnosis. References [1] Yaari, Z. et al., Science Advances, 2021. [2] Yaari, Z. et al., Nano Letters, 2020.

29 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ZYZvi Yaari
Zvi Yaari
YYYoona Yang
Yoona Yang
EAElana Apfelbaum
Elana Apfelbaum
ASAlex Settle
Alex Settle
QCQuinlan Cullen
Quinlan Cullen
DHDaniel A. Heller
Daniel A. Heller
Conventional molecular recognition elements, such as antibodies, present issues for the development of biomolecular assays for use in point-of-care devices, implantable/wearables, and under-resourced settings. Additionally, antibody development and use, especially for highly multiplexed applications, can be slow and costly. We developed a perception-based platform based on an optical nanosensor array that leverages machine learning algorithms to detect multiple protein biomarkers in biofluids. We demonstrated this platform in gynecologic cancers, which are often diagnosed at advanced stages, leading to low survival rates. We investigated the platform for detection in uterine lavage samples, which are enriched with cancer biomarkers compared to blood. We found that the method enables the simultaneous detection of multiple biomarkers in patient samples, with F1-scores of ~0.95 in uterine lavage samples from cancer patients. This work demonstrates the potential of perception-based systems for the development of multiplexed sensors of disease biomarkers without the need for specific molecular recognition elements.

30 May 2021 in ECS Meeting Abstracts
Verified
Journal Article
Closed access
DHDaniel A. Heller
Daniel A. Heller
ZYZvi A Yaari
Zvi A Yaari
MKMijin Kim
Mijin Kim
YYYoona Yang
Yoona Yang
CCChen Chen
Chen Chen
AJAnand Jagota
Anand Jagota
The photoluminescence of single-walled carbon nanotubes (SWCNTs) offers unique advantages for the development of biological sensors, including the potential to sensitize emission to many classes of analytes. Methods to selectively transduce the local concentration of an analyte via an optical signal often involve the attachment of existing molecular recognition elements to the nanotube surface, or the development of selectivities by high-throughput screening or selection techniques. Due to the existence of several mechanisms of optical modulation of SWCNTs, as well as multiple carbon nanotube species with differing bandgaps, and the increasing number of excipients and polymers that can be used for colloidal suspension and non-covalent functionalization, data analytics can be used to facilitate selective recognition of bioanalytes to detect and process multi-parametric spectroscopic fingerprints. These strategies will be discussed for the detection of single and multiplexed analytes.